We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Scalability in Cell-based Therapy Manufacture – Mind the Gap!

News   Feb 26, 2016

 
Scalability in Cell-based Therapy Manufacture – Mind the Gap!
 
 
Advertisement
 

RELATED ARTICLES

Recreating Nature: Chemists Create Synthetic Version of Natural Anti-Cancer Agent

News

Scripps Research chemists Hans Renata, PhD, and Alexander Adibekian, PhD, have discovered a way to efficiently create a synthetic version of a valuable natural compound called cepafungin I, which has shown promise as an anti-cancer agent.

READ MORE

Implanted Mouse Stem Cells Regain Their Function in Spinal Cord Injury

News

Researchers have reported successful regaining of function after implanting highly specialized grafts of neural stem cells directly into spinal cord injuries in mice.

READ MORE

NIH Announces Clinical Trial To Test Monoclonal Antibodies for COVID-19

News

A Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies (mAbs) to treat the disease.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE